Departments. Programmes. Cancer World e-eso Masterclass Clinical/Medical Oncology

Transcription

1

2 Departments Cancer World e-eso Masterclass Clinical/Medical Oncology Sharing Progress in Cancer Care Milan Via Turati, Milano - Italy Phone: Fax: eso@eso.net Bellinzona Piazza Indipendenza, Bellinzona - Switzerland Phone: Fax: eso@eso.net World Oncology Forum wof@eso.net Programmes Breast Cancer breast@eso.net Eastern Europe and Balkan Region balkans@eso.net Eurasia eurasia@eso.net Gynaeco-oncology gynaeconcology@eso.net Latin America latinamerica@eso.net Lung Cancer lung@eso.net Lymphoma lymphoma@eso.net Mediterranean Region mediterraneanregion@eso.net Prostate Cancer prostate@eso.net Rare Tumours raretumours@eso.net

3 The European School of Oncology continues the consolidated tradition of offering independent, updated and affordable oncological education for all professionals interested in learning to care. For 2018 there are a number of new initiative that we hope will help fulfilling your need of keeping your knowledge up to date. Renewed e-learning programme on the latest topics in oncology. The format of the e-eso session has been enriched with interactive case-discussion, conference reports and controversies. The collaboration with CROH will ensure up to date topics and the participation of the mostrenowned experts. Certificate of Competence in Lymphoma, Breast Cancer, in collaboration with Ulm University, and the Certificate of Advanced Studies in Lung Cancer being launched in cooperation with Zurich University for talented clinical oncologists and related specialists. University post graduate course on rare solid tumors of the adults in collaboration with Milan and other European Universities Fellowship grants for young oncologists to spend 3 to 6 months in clinical departments of European cancer centres chosen for their recognized excellence in clinical oncology and education. Also paediatric oncologists and nurses may apply in selected centres. Breast Cancer in Young Women International Conference (BCY4) with its state of the art consensus. Residential Masterclasses in Clinical Oncology in Western and in Eastern Europe, Balkan Region, Latin America and in the Eurasia and Baltic Region, encompassing case discussions and direct interaction between participants and teachers. In 2018 the offer is extended to Armenia thanks to the cooperation with ASCO. Masterclasses for Oncology Nursing, in collaboration with EONS, within the Residential Masterclasses in Clinical Oncology or as a self-standing event launched in 2018 within the Eastern European and Balkan region programme. Advanced/refresher courses in disease specific issues, including Gynecologic Oncology, Head and Neck Cancer. ESO observatories and sessions in lymphomas, breast, prostate, colorectal, lung cancer within prestigious international conferences. Patients and advocate empowerment programme as well as the expansion of the activities of the newly established Advanced Breast Cancer Global Alliance. Rare cancers programme with the traditional clinical update on rare adult solid cancers in collaboration with ESMO, RCE, EURACAN and Milan University. Residential courses for medical students to build up a knowledgeable community of future medical oncologists ready to face the challenges of this fascinating profession, in collaboration with ESMO, ESSO and ESTRO. Continuing collaboration with, ASCO, EAU, ECCO, EONS, ESGO-ENYGO, ESMO, ESNM, ESOP, ESSO, ESTRO, SIOPE, OECI and UICC within the common objective of expanding knowledge and teaching multidisciplinarity. The scientific magazine of the School, Cancerworld, is published four times a year, at the beginning of each season, in issues of 72 pages and it has now a print run of 20'000 copies. It is also available online at with weekly updates, open to comments, letters and announcements. With its editorial board of journalists from different European countries, Cancerworld stands as a unique tool to increase knowledge of health professionals in cancer medicine. Looking forward to meeting you at one of the ESO events, in person or online, Fedro A. Peccatori, MD Scientific Director Alberto Costa, MD CEO ESO EDUCATION

4 ESO EDUCATION 2018 E-ESO ONLINE EDUCATIONAL RESOURCES e-sessions (live and recorded on the internet) epatcare (clinical cases) MASTERCLASSES February rd ESO Masterclass in Cancer Patient Advocacy Lisbon, Portugal March th ESO-ESMO Masterclass in Clinical Oncology Nauen OT Groß Behnitz (Berlin), Germany March th ESO-EONS Masterclass in Oncology Nursing Nauen OT Groß Behnitz (Berlin), Germany June 2018 ESGO-ENYGO-ESO Masterclass in Gynaecological Oncology Warsaw, Poland June th ESO-SIOP EUROPE Masterclass in Paediatric Oncology Nauen OT Groß Behnitz (Berlin), Germany September 2018 ESO Masterclass in Neuro-Oncology: Multidisciplinary Management of Adult Brain Tumours Milan, Italy September rd Masterclass on Systematic Reviews in Cancer Care, Guidelines and Research Belfast, United Kingdom COURSES AND SEMINARS 16 June th Clinical Oncology Update - Onkologia 2018 Krakow, Poland July 2018 ESMO-ESO Course on Medical Oncology for Medical Students Valencia, Spain 26 August - 7 September 2018 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students Poznan, Poland 2-7 September 2018 ESMO-ESO Course on Medical Oncology for Medical Students Naples, Italy September 2018 Update Skills in Head and Neck Surgery and Oncology Leipzig, Germany 1-3 December rd ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers Milan, Italy and University Post-graduate Courses in Clinical Oncology of Rare Adult Solid Cancers 2018 Milan, Italy 2 ESO EDUCATION 2018 INSIDE TRACK CONFERENCES May th ESO-CNIO Familial Cancer Conference Madrid, Spain 6-8 October th ESO-ESMO Breast Cancer in Young Women International Conference (BCY4) Lugano, Switzerland November 2018 Biosimilars in Cancer Care: Challenges and opportunities for Health Professionals and Patients Barcelona, Spain EASTERN EUROPE AND BALKAN REGION PROGRAMME June th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology Belgrade, Republic of Serbia September st ESO-EONS Eastern Europe and Balkan Region Masterclass in Oncology Nursing Budapest, Hungary October 2018 Eastern Europe and Balkan Region Refresher Course on Gynaecological Tumours Sarajevo, Bosnia-Herzegovina

5 EURASIA July 2018 Baltic and Eurasia Masterclass in Clinical Oncology Riga, Latvia 9-13 November 2018 ESO-ASCO Masterclass in Clinical Oncology Yerevan, Armenia MEDITERRANEAN REGION December 2018 Mediterranean Masterclass in Clinical Oncology Limassol, Cyprus LATIN AMERICA PROGRAMME April th ESO-ESMO Latin American Masterclass in Clinical Oncology Mexico City, Mexico VISITING PROFESSORSHIP MEETINGS 5-6 April 2018 Visiting Professorship Meeting in Breast Cancer Pristina, Kosovo June 2018 Visiting Professorship Meeting in Lung Cancer Pristina, Kosovo ESO EDUCATION 2018 ESO OBSERVATORIES AND SESSIONS OBSERVATORIES AND S CAREER DEVELOPMENT ESMO Preceptorship on Immuno-Oncology Clinical Training Centres Fellowship Programme Certificate of Competence in Lymphoma (Fourth cohort ) Certificate of Competence in Breast Cancer (Third cohort ) Certificate of Advanced Studies in Lung Cancer ( ) Master Online Advanced Oncology Online Master in Molecular Oncology Online Master in Medical Oncology International Online Master Degree in Gynaecologic Oncology MEDIA ACTIVITIES Cancer World Journalism Award and Cancer World Journalist Network PUBLICATIONS Cancer World Magazine Critical Reviews in Oncology/Hematology (CROH) The Breast Tumori Journal BREAST CENTRES NETWORK PROSTATE CANCER UNITS NETWORK ABC GLOBAL ALLIANCE ESO EDUCATION

6 DISTANCE LEARNING e-eso learning platform e-eso is a platform dedicated to providing distance learning materials in the form of: E-sessions (live and recorded); Slides from ESO's events; Clinical cases. Materials are divided into categories: Recorded sessions (past live sessions that have been recorded and can be viewed online); Downloadable PDF presentations from past ESO events; Future sessions (scheduled sessions that will be presented live on the indicated date - participants can interact with the speakers during the sessions); Clinical cases (provided via epatcare, see below). ESO s live e-sessions are held every week on Thursday at 18:15-19:00 CET. Participants can either attend the live session or view the recorded session that is available 24 hours after the live session. e-sessions are CME accredited (except for the sponsored sessions and the sessions recorded at live events). Over 500 e-sessions on a variety of subjects have already been delivered to over 9,000 registered users from more than 130 countries! e-eso is proud of its collaboration with internationally renowned speakers and of the growing number of educational e-learning resources available on its website and openly accessible by all interested health professionals from across the globe, free of charge. More than 500 e-learning resources are available on the e-eso website! epatcare epatcare is a unique educational software tool developed to improve the dialogue between clinicians by providing interactive training, and to ultimately advance patient care. epatcare provides clinicians the opportunity to create, view, share and present their clinical patient cases within the Oncology Community. It focuses on the needs of this specific target group by offering a patient case sharing function via cloud. This interactive and intuitive platform enables users to easily create an attractive and appealing patient case that can be presented to an audience. This is what makes this tool truly valuable for HCPs. The intuitive handling of the software as well as a chronological, well-structured and comprehensible presentation of patient cases facilitates discussions with other oncologists or tutorials for students. A virtual journey guides the user through the patient's history from their presentation to investigation, diagnosis, management and outcomes, with all the patient's medical background and test results located in one convenient place. epatcare provides you with clinical real-life cases that have been seen and managed by oncology specialists. More than 70 cases available on the ESO epatcare platform! epatcare is developed by infill Kommunikation and the platform was provided by Boehringer Ingelheim. e-eso and epatcare online resources are available free of charge. For further information: Francesca Marangoni - fmarangoni@eso.net #e_eso 4 ESO EDUCATION 2018

7 E uropean School of O ncology Y our Educa tion, free and just a click away! e-learn with our experts, discussants and materials Access any materials available on the site at any time Connect LIVE on Thursday at 18:15 CET Interact by asking questions to our experts BEFORE, DURING and AFTER the live sessions Get CME credits Create your own e-eso agenda TOPICS Medical Oncology Surgical Oncology Radiation Oncology Haemato Oncology Nursing AND MUCH MORE! Keep up-to-date via #e_eso CONTENT THURSDAY, ENTER THE LIVE Highlights SESSION AND INTERACT Pathways 9:15 San Fran cisco Debates 12:15 Boston, New York Grandrounds 14:15 Buenos Aires Oncoreviews 17:15 Dublin, Lisbon, London Clinical cases 18:15 Madrid, Paris, Rome Slide lides 19:15 Cairo, Cap e Town, Tel Aviv 20:15 Moscow 21:15 Dubai 22:45 Mumbai Your regular appointments with education organised without commercial sponsorship by the European School of Oncology in collaboration oration with

8 3 RD ESO MASTERCLASS IN CANCER PATIENT ADVOCACY February Lisbon, Portugal Scientific Co-ordinator: K. Redmond, CH Steering Committee: V. Astratinei, RO - K. Benn, IT - S. Diler, TR - J. Geissler, DE - G. Henning, UK - T. Kolarova, BG L. Markoff, BE - K. Mastris, UK - K. Oliver, UK - A. Plate, DE - J. Taylor, UK - A. Stunt, UK - S. Wintrich, UK The Masterclass in Cancer Patient Advocacy was launched by the European School of Oncology in 2014 to meet the educational needs of highly experienced cancer patient advocacy leaders who have limited opportunities to develop their advocacy skills, get updated on key cancer policy issues and explore how to improve their organisation s performance. This third edition of the Masterclass will bring together senior representatives of European and international cancer patient Learning objectives: Help participants hone their advocacy and leadership skills Discuss ways of improving organizational impact and effectiveness Review state-of-the-art approaches to evidence based advocacy Provide participants with the opportunity to network and share experiences The Masterclass will be held in collaboration with the following cancer patient organisations: Childhood Cancer International (CCI), International Brain Tumour Alliance (IBTA), Europa Uomo, CML Advocates, Myeloma Patients Europe (MPE), Pancreatic Cancer Europe/World, Pancreatic Cancer Coalition, Europa Donna, International Neuroendocrine Cancer Alliance (INCA), European Cancer Patient Coalition (ECPC), European Men s Health Forum (EMHF), Europa Colon, Melanoma Patient Network Europe, MPNE Ocular/Rare Melanoma Group, International Kidney Cancer Coalition, EURORDIS, MDS Alliance, Lung Cancer Europe (LUCE), Lymphoma Coalition Europe, Thyroid Cancer Alliance ATTENDANCE IS BY INVITATION ONLY ATTENDEES WERE NOMINATED BY ORGANISATIONS networks as well as a small number of future leaders. To ensure that the Masterclass meets the needs of senior European cancer patient leaders, ESO has established a steering committee consisting of representatives from a number of the European cancer patient networks. Selected EU/international cancer patient networks will be invited to send two delegates to the Masterclass (in addition to their representative on the Steering Committee). Main topics: Lobbying for change Building effective and sustainable EU cancer patient networks (leadership, effectiveness, challenges of working with industry, Boards) Achieving sustainable access to cancer therapies Developing advocacy leadership skills (Communication, Persuasion & Influence, Coaching, Interpreting scientific data) Moving from anecdotal to evidence based advocacy Participant s profile: Highly experienced cancer patient advocates who are involved in one of the European cancer patient networks Future leaders of European cancer patient advocacy groups Fluency in English Corinne Hall, chall@eso.net, ph The European School of Oncology is grateful to the following companies for supporting the Masterclass: Amgen, AstraZeneca, Helsinn, Lilly, Merck, Novartis, Pfizer. Roche 6 ESO EDUCATION 2018

9 17 TH ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY March Nauen OT Groß Behnitz (Berlin), Germany Chairs: N. Pavlidis, GR - R. Stahel, CH Scientific Advisors: F. Lordick, DE - R. Popescu, CH The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be citedparticipants will deliver case presentations within tumour boards and small groups and discuss them with the chairs and the faculty. Informal discussion will be facilitated during the aperitifs and the lunches with the experts. All Learning objectives: Improve medical oncologists skills Help in preparing for the national board exam Practicing case discussion Deep focus on breast, gastro-intestinal, genitourinary, gynaecological, head and neck and lung cancers Compact update on communication skills, mind body medicine, molecular tumour boards, gender issues, melanoma and immunotherapy, immune-oncology, magnitude of benefits scale, sarcomas and GIST, adolescents and young adults, low nad high grade lymphomas, supportive and palliative care, management of elderly cancer patients, biosimilars and drug repositioning, ethical dilemmas participants will reside at the masterclass venue and participation is compulsory throughout the masterclass. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilst the communication skills and ethical dilemmas workshop will be attended jointly. Participant s profile: Age between 30 and 40 years At least 2-3 years experience in medical oncology or clinical oncology Involvement in scientific activities Fluency in English Main topics: Breast cancer Gastro-intestinal tumours Genito-urinary cancers Gynaecological cancers Head and neck cancer Lung cancer Held in collaboration with Part of the Master Online Advanced Oncology of Francesca Marangoni, fmarangoni@eso.net, ph Corinne Hall, chall@eso.net, ph BY APPLICATION ONLY THE APPLICATION DEADLINE HAS PASSED ESO EDUCATION

10 11 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING March Nauen OT Groß Behnitz (Berlin), Germany Chairs: C. Lacerda, PT - E. van Muilekom, NL Advisor: B. Grube, DK The Masterclass in Oncology Nursing programme is designed for European advanced cancer nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care. Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as assessment and decision making, communication skills, complex symptom management, research in nursing, psychosocial consequences of cancer therapy to mention a few. Other sessions will provide the forum for reviewing and Learning objectives: Understand new developments in oncology disease management Recognize and describe acute and late adverse effects of cancer and its treatment Identify complex patient needs across the cancer trajectory Demonstrate understanding of advanced communication skills in oncology nursing care Critically appraise the evidence for cancer symptom management and care interventions Reflect on theoretical underpinnings of decision making Describe the role of the advanced oncology nurse in leading clinical nursing care European Oncology Nursing Society, EONS Secretariat Brussels, Belgium Rudi Brike, eons.secretariat@cancernurse.eu, ph understanding the growing evidence base for nursing interventions and reflect on participant s role in clinical leadership. Case studies will be presented by the participants and will explore nursing practice focusing on special aspects of care. In joint sessions, nurses will, together with physicians, update their clinical knowledge with an international faculty of experts. Special joint sessions will highlight and support the growing need for multiprofessionality in chosen topics. Practical training will be offered in smaller group sessions, case study sessions focusing on skills necessary for patient care management. Participant s profile: Person working at an advanced nursing practice level, and with at least 3-5 years of clinical cancer nursing practice (a Master of Nursing Science degree is not mandatory) Person involved in direct patient care, also combined with the management, organisations and co-ordination of cancer patient care Fluent in English (reading and speaking) Member of an EONS member society or individual member of EONS Participants have been selected by means of a strict application review Main topics: Medical management, treatment options Effective symptom management and care interventions Understanding evidence based knowledge Newer areas of oncology nursing Improving patient experience and outcomes BY APPLICATION ONLY THE APPLICATION DEADLINE HAS PASSED 8 ESO EDUCATION 2018

11 4 TH ESO-ESMO LATIN AMERICAN MASTERCLASS IN CLINICAL ONCOLOGY April Mexico City, Mexico Chairs: A. Cervantes, ES - N. Pavlidis, GR - R.A. Stahel, CH Scientific Coordinators: M. Aapro, CH - F. Cardoso, PT The Masterclass is the most structured ESO educational activity whose format has been established and presented in Europe for over a decade. The success of the teaching method has been confirmed by the events held also in other parts of the world as well as by the three editions held in Latin America. It is with pleasure and gratefulness for the consideration of the local community, that ESO announces the fourth edition to be held in the region in The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and small groups and discuss them with the chairs and the faculty. As for all Masterclasses, the number of participants will be limited and admission will be by competitive application only. Admitted participants will be granted free registration and half-board accommodation for the duration of the Masterclass. Learning objectives: Improve medical oncologists skills Practicing case discussion Deep focus on breast, gastro-intestinal, genitourinary, gynaecological, head and neck and lung cancers Compact update on further topics of interest Luis Carvalho, lcavalho@eso.net, ph Alice Ciocchini, aciocchini@eso.net, ph Held under the auspices of Participant s profile: Age between 30 and 40 years At least 3 years experience in medical oncology (or clinical oncology) Involvement in scientific activities (desirable) Intermediate level of English language Practicing in Latin America Main topics: Breast cancer Gastro-intestinal cancers Genito-urinary cancers Gynaecological cancers Head and neck cancer Lung cancer BY APPLICATION ONLY THE APPLICATION DEADLINE HAS PASSED ESO EDUCATION

12 8 TH ESO-CNIO FAMILIAL CANCER CONFERENCE May Madrid, Spain Chairs: R. Eeles, UK - W. Foulkes, CA - M. Robledo, ES - H. Vasen, NL The ESO and CNIO Conference on Familial Cancer aims to present the advances in this field from a multidisciplinary point of view. Due to its implications not only at individual but also at the familial and social level, familial cancer has become an important challenge for oncologists, geneticists, molecular biologists and other professionals.. Along the last years, new approaches have allowed to increase our knowledge about the genes responsible for familial cancer as well as their biological functions factors that are essential in identifying the appropriate treatment in each case. The next generation sequencing is extensively used in the search of causal mutations but it represents a new challenge regarding the interpretation of Learning objectives: Improve the understanding of the selection criteria the landscape of breast and ovarian cancer genes, and their clinical impact Update the knowledge about genetics and clinical management of hereditary colorectal cancer Appraise herapeutic strategies in the era of personalized medicine and implications of applying next generation sequencing to the diagnosis Learn about translating genetic risk factors to the surveillance and clinical management of prostate cancer Update the knowledge about rare cancers: new genes, new approaches, new challenges variants, many of which must be classified as of unknown significance. Biannually the Conference brings together leading basic and translational researchers and clinicians involved in the diagnosis, treatment and follow-up of patients with familial cancer. These meetings help to establish connections among professionals that in turn promote progress in the understanding and treatment of these diseases. Besides the lectures from international experts, young scientists can present their work as short lectures and posters. This format aims to facilitate extensive discussion of current issues and stimulate new ideas. Main topics: Breast and ovarian cancer Colon and prostate cancer Rare cancers Implications of applying next generation sequencing to the diagnosis Luis Carvalho, lcarvalho@eso.net, ph Daniela Mengato dmengato@eso.net, ph DEADLINES EARLY REGISTRATION: 31 MARCH 2018 LATE REGISTRATION: 30 APRIL ESO EDUCATION 2018

13 ESGO-ENYGO-ESO MASTERCLASS IN GYNAECOLOGICAL ONCOLOGY June Warsaw, Poland Scientific and organizing committee: D. Querleu, FR - F. Peccatori, IT - K. Zalewski, PL This full-immersion, clinically oriented, multidisciplinary event offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines. State-of-the-art lectures will be combined with practical video presentations of surgical approaches and tumour boards where discussion times have been extended. Furthermore, selected participants will have the unique opportunity to present and discuss their clinical case study. Learning objectives: Update the knowledge on the entire curriculum of the gynae-oncological subspecialty as defined by ESGO, which defines the European standards of training and care in gynaecological oncology Improve knowledge on different types of gynaecological cancers, their treatment and care Improve knowledge of anatomy, cervical endometrial, ovarian and vulvar cancer Participant s profile: Age between 30 and 40 years Trainee or fellow in gynaecological oncology Fluency in English Main topics: Pelvic anatomy applied to gynaecological cancer surgery Cervical cancer Vulvar cancers Malignant tumours of the uterus Malignant tumours of the ovaries Miscellaneous (palliative care, side effects of chemotherapy, targeted therapy) Workshops: Presentation of selected clinical cases by participants with discussion European Society of Gynecological Oncology (ESGO) Prague, Czech Republic Helena Opolecka, masteclass2018@esgomail.org, ph DEADLINE BY APPLICATION ONLY: 15 APRIL 2018 ESO EDUCATION

14 5 TH ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN MEDICAL ONCOLOGY June Belgrade, Republic of Serbia Chairs: A. Eniu, RO - N. Pavlidis, GR - C. Zielinski, AT The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. The programme has been designed for young medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology. Participants will deliver case presentations within tumour boards and small groups and discuss them with the chairs and the faculty. Admitted participants will be granted free accommodation and reside at the course venue. Participation is compulsory throughout the course. The Masterclass will be held in English and fluency in English is necessary for admission. Learning objectives: Update the knowledge on basic science of clinical and medical Oncology Enhance the competence and practical performance in systemic therapy of malignancies Enhance the competence and practical performance in multidisciplinary cancer care Update knowledge and get additional skills in supportive as well as palliative care Prepare for the board exam in clinical/medical oncology Dolores Knupfer, dknupfer@eso.net, ph Laura Richetti, lrichetti@eso.net, ph Participant s profile: Age between 30 and 40 years 2-4 years experience in oncology Involvement in scientific activities and clinical trials Fluency in English Practicing in Eastern Europe and Balkan Region Main topics: Cancer biology/pathology Cancer genetics Pharmacology of anti-cancer drugs Breast cancer Gastro-intestinal tumours Lung cancer and mesothelioma Genito-urinary cancers Palliative and supportive care Lymphoma malignancies BY APPLICATION ONLY THE APPLICATION DEADLINE HAS PASSED 12 ESO EDUCATION 2018

15 SIOP SIOP Europe the European Society for Paediatric Oncology 7 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June Nauen OT Groß Behnitz (Berlin), Germany Chairs: S. Bielack, DE - A. Eggert, DE - B. Morland, UK - R. Riccardi, IT ESO and SIOP Europe are pleased to announce the seventh Masterclass in Paediatric Oncology. This clinically-oriented educational programme has been designed for young paediatric oncologists who wish to improve their skills in clinical management of common childhood tumours. It is designed to offer a unique learning experience, providing practice-oriented training and the teaching sessions will focus on the application of the most recent research findings to clinical practice. Practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants for an interactive discussion. All participants will reside at the Masterclass venue and participation is mandatory throughout the course. Learning objectives: Receive qualified training in paediatric oncology to improve knowledge of the main topics listed below Improve skills in dealing with cancer problems as a whole Improve knowledge of current clinical practice and state of the art treatment Improve doctor-patient communication as well as doctor-parent communication Participant s profile: Age between 30 and 40 years 2-4 years experience in paediatric oncology Involvement in scientific activities and clinical trials Fluency in English Main topics: Central nervous system tumours Neuroblastoma Soft-tissue sarcoma Bone tumours Wilms tumour Rare tumours Alice Ciocchini, aciocchini@eso.net, ph Alexandra Zampetti, azampetti@eso.net, ph BY APPLICATION ONLY THE APPLICATION DEADLINE HAS PASSED ESO EDUCATION

16 10 TH CLINICAL ONCOLOGY UPDATE ONKOLOGIA June Krakow, Poland Scientific Coordinator: W.M. Wysocki, PL The 2018 conference programme will include special sessions designed for in-training oncologists with question-and-answer modules and simulated board certification tests in oncology. It will furthermore offer plenary lectures delivered by the leading experts in the field, focusing on the state-of-the-art therapies and concluding with take-home messages. Lectures will cover the current standards of modern oncology, with special attention to practical aspects of effective cancer treatment. Multidisciplinary interactive sessions will be opened also for non-oncologists dealing with cancer patients (radiologists, pathologists, general practitioners, etc.). The Learning objectives: Update on the most important advances in the field of gastrointestinal malignancies (including liver), breast cancer, melanoma, gynaecological malignancies and lung cancer Improve the skills and knowledge on practical clinical issues, such as management of common treatment-related toxicities, nausea and vomiting prophylaxis, cancer emergencies and specific problems with immunotherapies Medycyna Praktyczna - Conferences Liszki, Poland Michał Bańdo, michal.bando@mp.pl, ph conference will be held in English and further languages, for which simultaneous translation in English will be provided. European experts in oncology, invited jointly by ESO and Medycyna Praktyczna, will deliver lectures on practical clinical issues, including management of patients with gastrointestinal malignancies (including liver), current strategies in gynaecological oncology and advanced lung cancer, management of breast cancer (including novel therapeutic options), treatment of urinary tract malignancies, skin malignancies and oncological emergencies. Participant s profile: Medical oncologists, radiation oncologists and surgical oncologists Other medical specialties involved in cancer care (e.g. radiologists, pathologists, general practitioners, etc.) Medical students and nurses Main topics: Lung cancer Breast cancer (including disseminated disease) Melanoma and other skin malignancies Gastro-intestinal malignancies (including liver) Gynaecological malignancies Treatment-related toxicities DEADLINES EARLY REGISTRATION: 13 MAY 2018 LATE REGISTRATION: 10 JUNE ESO EDUCATION 2018

17 BALTIC AND EURASIA MASTERCLASS IN CLINICAL ONCOLOGY July Riga, Latvia Chairs: N. Pavlidis, GR - F. Peccatori, IT Scientific Advisors: J. Eglitis, LV This residential programme has been designed for medical, clinical and radiation oncologists, who wish to improve their skills in multidisciplinary care management. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. The programme focuses on lung, breast, gastrointestinal, head and neck cancers. Spotlight sessions will facilitate compact update on supportive care and melanoma. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion. All participants will reside at the Masterclass venue and participation is mandatory throughout the course. Learning objectives: Update the knowledge on basic science of clinical and medical oncology Enhance the competence and practical performance in systemic therapy of malignancies Enhance the competence and practical performance in multidisciplinary cancer care Update knowledge and get additional skills in supportive as well as palliative care Participant s profile: Age up to 40 years At least 2-3 years experience in medical or clinical oncology Involvement in scientific activities Intermediate level of English Practicing in Baltic and Eurasian countries Main topics: Lung cancer Breast cancer Gastrointestinal tumours Head and neck cancers Palliative and supportive care Alice Ciocchini, aciocchini@eso.net, ph Daniela Mengato, dmengato@eso.net, ph DEADLINE BY APPLICATION ONLY: 31 MARCH 2018 ESO EDUCATION

18 ESMO-ESO COURSE ON MEDICAL ONCOLOGY FOR MEDICAL STUDENTS July Valencia, Spain Chair: A. Cervantes, ES Co-Chairs: N. Pavlidis, GR - M. Preusser, AT The ESMO-ESO five-day residential course is open to fourth and fifth-year medical students and will focus on medical oncology. The course will provide an insight into all aspects of medical oncology, enabling students to get a full picture of this challenging and interesting professional field before making the choice of their specialization. The condensed high-standard educational programme aims to motivate medical students to choose medical oncology as a career. Learning objectives: Increase knowledge in medical oncology, filling the gap in the medical student s curriculum Acquire the skills to discuss clinical cases with a multidisciplinary approach Enhance and broaden medical education and learning experience Participant s profile: Fourth and fifth year medical students Fluency in English European Society for Medical Oncology Lugano, Switzerland Doris Vola, education@esmo.org, ph Main topics: A practical approach to cancer diagnosis, staging, prognosis and therapy Principles of medical therapy for cancer Breast cancer Colorectal cancer Gastric cancer Ovarian cancer Lung cancer Melanoma Prostate cancer Renal cell carcinoma Testicular cancer Held in cooperation with DEADLINE BY APPLICATION ONLY: 15 APRIL ESO EDUCATION 2018

19 ESO-ESSO-ESTRO MULTIDISCIPLINARY COURSE IN ONCOLOGY FOR MEDICAL STUDENTS 26 August - 7 September Poznan, Poland Educational Committee: J. Eriksen, DK - N. Pavlidis, GR - S. Sandrucci, IT - J.B. Vermorken, BE Local Organiser: R. Madry, PL ESO (European School of Oncology), ESSO (European Society of Surgical Oncology) and ESTRO (European Society for Radiotherapy and Oncology) are pleased to announce the jointly organised multidisciplinary course in oncology for medical students. The key goal of this course is encouraging medical students to specialize in an oncology related discipline. Previous editions organized by ECCO (European Cancer Organisation) since 2005 got very positive and enthusiastic feedback from the students who had spent two weeks over summer with experienced teachers to receive Learning objectives: Have a comprehensive understanding of all aspects of oncology Have an understanding of the complexity and importance of the multidisciplinary approach to cancer treatment Prepare a specific topic related to the theoretical and/or practical sessions and present it to plenary audience Participant s profile: Fourth year medical students Fluency in English Held in cooperation with Cooperation for promotion provided by theoretical and practical training in cancer care. The multidisciplinary course in oncology will provide insight into all aspects of oncology with both theoretical and practical sessions. The programme incorporates plenary sessions, case study presentations, daily special visits to various oncology departments and group course projects that must be finalized and presented at the end of the course. The course has been designated for European Credit Transfer and Accumulation System Credits (ECTS). Main topics: History, epidemiology, genetics, diagnostics, treatment principles and therapeutic approaches, prevention and screening Communication with the patient Breast cancer Colorectal cancer Gastro-intestinal cancers Genito-urinary cancers Gynaecological cancers Head and neck cancer Lung cancer Sarcoma and melanoma Dolores Knupfer, dknupfer@eso.net, ph DEADLINE BY APPLICATION ONLY: 31 MAY 2018 ESO EDUCATION

20 ESMO-ESO COURSE ON MEDICAL ONCOLOGY FOR MEDICAL STUDENTS 2-7 September Naples, Italy Chair: A. Cervantes, ES Co-Chairs: N. Pavlidis, GR - M. Preusser, AT This The ESMO-ESO five-day residential course is open to fourth and fifth-year medical students and will focus on medical oncology. The course will provide an insight into all aspects of medical oncology, enabling students to get a full picture of this challenging and interesting professional field Learning objectives: Increase knowledge in medical oncology, filling the gap in the medical student s curriculum Acquire the skills to discuss clinical cases with a multidisciplinary approach Enhance and broaden medical education and learning experience Participant s profile: Fourth and fifth year medical students Fluency in English European Society for Medical Oncology Lugano, Switzerland Doris Vola, education@esmo.org, ph before making the choice of their specialization. The condensed high-standard educational programme aims to motivate medical students to choose medical oncology as a career. Main topics: A practical approach to cancer diagnosis, staging, prognosis and therapy Principles of medical therapy for cancer Breast cancer Colorectal cancer Gastric cancer Ovarian cancer Lung cancer Melanoma Prostate cancer Renal cell carcinoma Testicular cancer Held in cooperation with Cooperation for promotion provided by DEADLINE BY APPLICATION ONLY: 15 APRIL ESO EDUCATION 2018

21 1 ST ESO-EONS EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN ONCOLOGY NURSING September Budapest, Hungary Chairs: A. Eniu, RO - B. Grube, DK - L. Sharp, SE This Masterclass in Oncology Nursing is specifically designed to meet the educational needs of cancer nurses from Eastern Europe and Balkan region and, to facilitate the interaction, simultaneous translation in regional languages will be provided. Three intensive days of full immersion in up-to-date cancer nursing will create a collective spirit of teaching and learning to improving clinical skills and patient care. The sessions will provide specialist knowledge on the main topics that will be addressed in the Masterclass either in plenary Learning objectives: Understand new developments in cancer disease management Recognize and describe acute and late adverse effects of cancer and its treatment Identify complex patient needs across the cancer trajectory Describe the role of the advanced oncology nurse in leading clinical nursing care or during small group sessions. The number of participants will be limited and admission will be by competitive application only. Admitted participants will be granted free registration and full-board accommodation for the duration of the Masterclass. An amount of maximum 250 Euro will be available as a contribution for travel support to participants not coming from the Budapest area. All participants will reside at the course venue and participation is compulsory throughout the course. Participant s profile: 5-10 years experience in cancer nursing Main topics: Cancer and lifestyle Radiotherapy, Emergency oncology Supportive and palliative care Team communication and safety Chemotherapy, targeted and immunotherapy Psychosocial issues Compassion fatigue Clinical leadership Case discussion on above topics Dolores Knupfer, dknupfer@eso.net, ph Laura Richetti, lrichetti@eso.net, ph DEADLINE BY APPLICATION ONLY: 31 MAY 2018 ESO EDUCATION

22 ESO MASTERCLASS IN NEURO-ONCOLOGY: MULTIDISCIPLINARY MANAGEMENT OF ADULT BRAIN TUMOURS September Milan, Italy Chairs: P. Mortini, IT - G. Pesce, CH The Masterclass offers plenary lectures regarding state-ofthe-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages in management of adult brain tumours. Participants will deliver case presentations within groups sessions: These sessions will also give to the participants the opportunity to exchange ideas with the experts about the proper management of the more problematic cases encountered in the daily practice while treating patients with brain tumours. All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Learning objectives: Improve of neurologists, radiation oncologists, medical oncologists and surgical oncologists/neuro-surgeons skills Practicing case discussions Update on the current standards of neurosurgery with special focus on intraoperative imaging, monitoring and neuro-navigation Improve the knowledge on current radiotherapy standards and techniques (IMRT, stereotactic radiosurgery, protons, etc.) Update on epidemiology, combination of radiotherapy with surgery and drug therapy, clinical trials management Luis Carvalho, lcavalho@eso.net, ph Laura Richetti, lrichetti@eso.net, ph Participant s profile: Neurologists, radiation oncologists, medical oncologists and surgical oncologists/neuro-surgeons with at least 2 years experience in neurosurgery, radiotherapy or neuro-oncology Aged between 30 and 40 years Involvement in scientific activities (desirable) Fluency in English Main topics: Clinical management of patients with primary and metastatic brain tumors Technical improvements, altered fractionation, specific aspects of high precision radiotherapy, radiosurgery, chemo-sentitization and other aspects of medical therapy Supportive treatments, symptom control both in palliative and curative intent DEADLINE BY APPLICATION ONLY: 27 MAY ESO EDUCATION 2018

23 3 RD MASTERCLASS ON SYSTEMATIC REVIEWS IN CANCER CARE, GUIDELINES AND RESEARCH September Belfast, United Kingdom Chair: M. Clarke, UK This five-day course will take participants through the key steps in preparing a systematic review of research in cancer that they can use to make decisions about treatment, guidelines or the design of new research. Each participant will bring a topic for a systematic review to the Masterclass, and this will form the basis of the problem-based learning approach that will be used throughout the course. Each day of the Masterclass will include formal lectures from experts in the relevant topic area, as well as group discussions Participant s profile: Healthcare practitioners with at least two years experience in the provision of care to cancer patients Familiarity with research into the effects of interventions for cancer patients, including randomized trials Basic understanding of the role of systematic reviews as a source of knowledge for decision making Fluency in English Main topics: Question formulation for systematic reviews Eligibility criteria and outcome selection Search strategy Study quality and risk of bias Statistical analysis and heterogeneity Implications for practice and research relating to that topic area, drawing on the knowledge of the expert. The group discussions will be a mixture of whole-group work, and smaller discussions in which participants will work in small parallel groups to tackle specific issues relating to their review questions. These small group sessions will conclude with a plenary session in which one member of each small group will provide feedback to all the participants on specific issues discussed about the reviews in their small group. Learning objectives: Formulation of the question Choice of inclusion and exclusion criteria, and selection of outcomes Development and implementation of a search strategy Application of the inclusion and exclusion criteria, and appraisal of quality and risk of bias in potentially eligible studies Data extraction Planning and conduct of meta-analyses, including subgroup and sensitivity analyses Exploration of heterogeneity Drawing conclusions and discussing implications for practice and research Francesca Marangoni, fmarangoni@eso.net, ph Alice Ciocchini, aciocchini@eso.net, ph Held in collaboration with DEADLINE BY APPLICATION ONLY: 1 JUNE 2018 ESO EDUCATION

24 UPDATE SKILLS IN HEAD AND NECK SURGERY AND ONCOLOGY September Leipzig, Germany Course Director: A. Dietz, DE Organising Committee: S. Wiegand, DE - G. Wichmann, DE - C. Standke, DE - R. Wyrwas, DE The four-day course of systematic presentation of head and neck oncology focuses on current concepts in surgery, radiation oncology and medical oncology. The programme includes lectures, workshops, active cadaver preparations and life surgery. The course delivers current knowledge about standard procedures and controversies in head and neck oncology like adjuvant treatment, induction chemotherapy, immune oncology, organ preservation and de-escalation concepts in HPV positive oropharyngeal cancer. Furthermore, functional aspects and surgical/phoniatric rehabilitation will be addressed. Participants are integrated in active interdisciplinary discussions. Teaching in life surgeries and videos includes systematic in neck dissection, laryngeal partial resection techniques and surgery and approaches to different sites of head and neck. The course will therefore deliver concepts and raise awareness of evidence-based modern head and neck oncology. Learning objectives: Update knowledge on evidence-based modern head and neck oncology Improve skills through life surgery and interdisciplinary discussions Main topics: Head and neck surgery Neck dissection Reconstructive surgery TLM, TORS Multimodality treatment Chemotherapy Immuno-oncology Adjuvant post-operative treatment Organ preservation Participant s profile: ENT, head and neck surgeons Clinical and medical oncologists Radiologists Phoniatricians Pathologists Radiation oncologists Universitäts-HNO-Klinik Leipzig, Germany Carola Standke, carola.standke@medizin.uni-leipzig.de, ph Held in cooperation with DEADLINES EARLY REGISTRATION: 30 JUNE 2018 REGULAR REGISTRATION: FROM 1 JULY ESO EDUCATION 2018

25 4 TH ESO-ESMO BREAST CANCER IN YOUNG WOMEN INTERNATIONAL CONFERENCE 6-8 October Lugano, Switzerland Chair: O. Pagani, CH; Scientific committee: F. Cardoso, PT - N. Harbeck, DE - S. Paluch-Shimon, IL A. Partridge, US - F. Peccatori, IT - E. Senkus, PL - Y. Wengström, SE Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g. etiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment and Learning objectives: In depth learning and update of the scientific and clinical aspects of breast cancer in young women Highlight the importance of multi-disciplinary management and discuss difficult clinical cases Focus on clinical research priorities and future perspectives, involving patients advocates in setting the agenda Participate in the discussion of consensus guidelines Participant s profile: Medical oncologists Surgeons Gynecologists Radiation oncologists Breast radiologists Onco-geneticists Pathologists Nurses Patient advocates Psycho-oncologists specific survivorship issues (fertility and job among others). This fourth conference is a new opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations. It will cover epidemiology, molecular biology, genetics, pathology, surgery, radiotherapy, systemic therapy, survivorship issues in young women with breast cancer. It will also include a consensus session that will form the basis for a consensus guidelines manuscript to be published after the Conference. Main topics: Epidemiology of early and advanced disease Biology Hereditary breast cancer Diagnostic tools and challenges Loco-regional therapy Systemic therapy Psychosocial aspects and survivorship Patient Advocates Workshop A workshop on what advocates should know about breast cancer in young women will be added at the end of the conference. Francesca Marangoni, fmarangoni@eso.net, ph: Luis Carvalho, lcavalho@eso.net, ph Alice Ciocchini, aciocchini@eso.net, ph DEADLINES ABSTRACTS AND TRAVEL GRANTS: 6 MAY 2018 EARLY REGISTRATION: 17 JUNE 2018 LATE REGISTRATION: 23 SEPTEMBER 2018 ESO EDUCATION

26 EASTERN EUROPE AND BALKAN REGION REFRESHER COURSE ON GYNAECOLOGICAL TUMOURS October Sarajevo, Bosnia-Herzegovina Chairs: S. Beslija, BA - C. Sessa, CH The Refresher Course on Gynaecological Tumours has been designed for medical and clinical oncologists of the Eastern Europe and Balkan Region, with the aim to provide an update on the -state of-the art therapeutic options as well as an overview of the latest advances in the field. The programme will offer educational lectures covering updates on the diagnosis and treatment of both early and advanced gynaecological cancers. Moreover, spotlight lectures will discuss specific issues related to particular situations such as gynaecological cancer in young women or survivorship issues. Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty with interactive voting. Learning objectives: Update on the latest advances in diagnostic procedure Update on the latest advances and on the state-of- the-art treatment options Learn about the management of specific situations Debate controversies and challenges in gynaecological cancer treatment Improve practical skills in multidisciplinary management and follow-up of gynaecological cancer patients Laura Richetti, lrichetti@eso.net, ph Participant s profile: Age between 30 and 45 years 2-4 years experience in oncology Involvement in scientific activities and clinical trials Fluency in English Practicing in Eastern Europe and Balkan Region Main topics: Update on standard and new diagnostic, treatment options and approaches Signalling pathways Gynaecological cancer pathology Systemic treatment of early and advanced gynaecological cancer DEADLINE BY APPLICATION ONLY: 15 JUNE ESO EDUCATION 2018

27 ESO-ASCO MASTERCLASS IN CLINICAL ONCOLOGY 9-13 November Yerevan, Armenia Chairs: G. Curigliano, IT - F. Peccatori, IT Host Chair: G. Tamamyan, AM This clinical oriented educational programme has been designed for medical, surgical and radiation oncologists and, in the selection process, priority will be given to applicants practicing in Caucasus, Eastern Europe, former Soviet Republics and Middle East who wish to improve their knowledge and skills in multidisciplinary cancer management. The programme will expose participants to a full spectrum of issues in clinical oncology and practice-oriented training, focusing on breast, gastro-intestinal, gynaecologic, lung and prostate cancers and furthermore include professional development topics. Experts will deliver state-of-the-art lectures on specific cancers followed by multidisciplinary tumour board discussions. Faculty members and participants will discuss aspects of medical, surgical, and radiation therapeutic options and how they can be used together for optimal patient outcomes. Furthermore, participants will deliver clinical case presentations within small groups. Attendance will be by competitive application only and admitted participants will be granted free registration and full-board accommodation. Learning objectives: Advance participants knowledge in the treatment of breast, gastrointestinal, gynaecologic, lung and prostate cancers Encourage attendees to adopt a multidisciplinary approach to the management of patients Increase understanding of roles and responsibilities of oncology team members in the delivery of quality cancer care Main topics: Breast cancer Lung cancer Gastro-intestinal cancers Gynaecological cancers Prostate Cancer Participant s profile: Age between 25 and 40 years At least 2-3 years experience in clinical oncology (medical oncology, radiation oncology, surgical oncology) Involvement in scientific activities (desirable) At least intermediate level of English language (simple scientific discussion in English) Priority will be given to applicants practicing in Caucasus, Eastern Europe, former Soviet Republics and Middle East Alice Ciocchini, aciocchini@eso.net, ph Daniela Mengato, dmengato@eso.net, ph Held in collaboration with DEADLINE BY APPLICATION ONLY: 15 JUNE 2018 ESO EDUCATION

28 BIOSIMILARS IN CANCER CARE: CHALLENGES AND OPPORTUNITIES FOR HEALTH PROFESSIONALS AND PATIENTS November Barcelona, Spain Chairs: M. Aapro, CH - G. Curigliano, IT Over the past two decades, the United States and Europe experienced a dramatic and unsustainable rise in cancer health care costs. Eight of the top ten most expensive drugs are cancer drugs, notably the novel biologic agents arising out of the recent revolution in our understanding of the genetic and molecular basis of malignancy. As the protective patents on new biologic therapies reach expiration, the race to develop biosimilars has begun, hopefully increasing competition and reducing costs. Although the U.S. Food and Drug Administration (FDA) and the European Medicine Agency (EMA) have developed Learning objectives: Explain the importance of analytical studies in development and regulatory approval of biosimilars Describe the concepts of immunogenicity and extrapolation of indications based on evaluation of the totality of the evidence and mechanism of action rationale Appraise the importance of pharmacoeconomics and access to biological oncology medicines in Europe Discuss the potential clinician-, nurse-, pharmacist-, and patient-specific issues relating to the suboptimal use of biosimilars and strategies to mitigate them Summarize current and emerging data on oncology monoclonal antibody biosimilars and their potential to enable optimal combination therapy DEADLINES EARLY REGISTRATION: 26 AUGUST 2018 LATE REGISTRATION: 4 NOVEMBER 2018 regulations for the development and approval of biosimilars, it remains uncertain how rapid and broad their entry will be. The reasons for such uncertainty are multiple but fundamentally relate to the biologic nature of these agents: these drugs, unlike generic pharmaceuticals, are large, complex molecules derived from biologic processes that are similar but not identical to the original agent and, thus, subject to immunogenicity and drift over time. The demonstration of comparable efficacy and safety to the originator is a challenge for both regulators and companies, necessitating careful pharmacovigilance following approval. Participant s profile: Oncology health care practitioners Medical oncologists Surgical oncologists Radiation oncologists Pharmacists and physicians Patient advocates and nurses, involved or interested in treatment of cancers Main topics: Technologies platform to develop biosimilars How to demonstrate biosimilarity with EMA How to demonstrate biosimilarity with FDA Principles of Extrapolation Clinical impact of biosimilar in clinical practice Financial impact of biosimilars Laura Richetti, lrichetti@eso.net, ph Luis Carvalho, lcavalho@eso.net, ph ESO EDUCATION 2018

29 3 RD ESO-ESMO-RCE CLINICAL UPDATE ON RARE ADULT SOLID CANCERS 1-3 December Milan, Italy Chairs: J.Y. Blay, FR - P.G. Casali, IT - R. Stahel, CH The third edition of the advanced course on rare adult solid cancers, which involves ESO, ESMO and Rare Cancers Europe, will be structured in two different levels of teaching: First day - Parallel Preceptorships for young oncologists (state-of-the-art treatment, with a special view to ESMO and ESMO/EURACAN Clinical Practice Guidelines) on the basics of rare adult solid cancers. Each attendee will be able to select three such cancers (three preceptorships will be held in parallel, each on three rare cancers amongst the following: Sarcomas, Rare Thoracic Tumors and Neuroendocrine Tumors, Rare Urogenital Cancers, Rare Female Genital Cancers, CNS Tumors, Digestive Rare Cancers, Head and Neck Cancers, Endocrine Learning objectives: Update senior and junior clinical oncologists with latest clinical developments on rare adult solid cancers Provide young oncologists with basic knowledge on the multidisciplinary care of rare adult solid cancers Main topics: Rare skin cancers and non-cutaneous melanoma Rare thoracic tumors Rare female genital cancers Neuroendocrine tumors Endocrine gland tumors Sarcomas - Digestive rare cancers - Rare urological and male genital tumors - Central nervous system neoplasms - Head and neck cancers Gland Tumors, Rare Skin Tumors and Uveal Melanoma). Second and third day: Clinical Update on the ten families of rare adult solid cancers, to provide the community of clinical oncologists interested in these tumors with the most recent advances in this specific area. Lectures will be multidisciplinary and clinically oriented. Given the success of the 2017 first edition, the Patient Advocates Course organized by Rare Cancers Europe will be run in parallel, again with some joint lectures in plenary session. These two initiatives are developed into the context of the European Reference Network on Rare Adult Solid Cancers, EURACAN. Many speakers and moderators will come from EURACAN, with the aim to serve the network. Participant s profile: Medical Degree Specialization/Residency in medical oncology, radiation oncology, surgical oncology or equivalent Fluency in English Marina Fregonese, mfregonese@eso.net, ph Held in collaboration with Held in in the framework of DEADLINE TO BE ANNOUNCED ESO EDUCATION

30 UNIVERSITY POST-GRADUATE COURSES IN CLINICAL ONCOLOGY OF RARE ADULT SOLID CANCERS University of Milan, Italy The University of Milan, Italy, in close collaboration with ESO will launch a programme of post-graduate courses on rare adult solid cancers. Each of them will last one week (30 hours) and will focus on one of the ten families of rare adult solid cancers. This programme is addressed to an international audience of clinical oncologists interested in advancing their knowledge and skills on one or more adult solid cancers. Courses will be highly multidisciplinary, held in English and be grant European and Italian CME credits. Both ESO and the Participant s profile: Medical degree Current involvement in clinical activities in the oncology area (with preference to rare cancers) CLINICAL ONCOLOGY: SARCOMAS January University of Milan, Italy Scientific Coordinator: P.G. Casali, IT Main topics: Natural history, epidemiology and pathology of sarcomas Clinical Management of soft tissue sarcomas, bone sarcomas and GIST Clinical cases discussion University of Milan are involved as associated partners in the new established EURACAN, the European Reference Network on rare adult solid cancers. Thus, this educational effort is addressed to reinforce the collaboration among oncologists of different countries already involved in EURACAN, or in networks related to EURACAN, or willing to be part of it in the future. Admission to the course will be by competitive application only. Attendance is limited to 30 participants. Two courses have been already scheduled at the beginning of Marina Fregonese, mfregonese@eso.net, ph Updated information available at CLINICAL ONCOLOGY: HEAD & NECK CANCERS 5-9 February University of Milan, Italy Scientific Coordinator: L. Licitra, IT Main topics: Natural history, biology, epidemiology, imaging and pathology of head and neck cancers Clinical Management of: Oral cavity and oropharyngeal cancers; Larynx and hypopharynx cancers; Nasopharyngeal and paranasal cancers; Salivary glands Clinical cases discussion and issues in head and neck cancers Held in collaboration with Held in in the framework of BY APPLICATION ONLY THE APPLICATION DEADLINES HAVE PASSED 28 ESO EDUCATION 2018

31 MEDITERRANEAN REGION MASTERCLASS IN CLINICAL ONCOLOGY December Limassol, Cyprus Chairs: M. Aapro, CH - N. Pavlidis, GR Host Chair: D. Papamichael, CY This is a four-days clinically oriented educational programme dedicated to medical, clinical and radiation oncologists, who wish to improve their skills in oncology. The programme focuses on breast, gynaecological, prostate, colorectal, lung cancers and on lymphomas and its covered by an international faculty of top experts. The Masterclass offers: plenary lectures regarding state-of-the art clinical evaluation and treatments with reference to clinical guidelines concluding in take-home messages; clinical case presentations will be delivered by the participants in Tumor Board discussions as well as in divided small groups with the presence of the chairmen and the faculty; a self-assessment test based on multiple choice questionnaire, will be provided to participants on the last day of the Masterclass. All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be held in English and fluency in English is necessary for admission. Learning objectives: Improve medical and radiation oncologists skills Practicing case discussion Deep focus on breast, gynaecological, prostate, lung and colorectal cancer, lymphomas Participant s profile: Age up to 40 years At least 2-3 years experience in the field (medical /clinical oncology) At least an intermediate level of English Involvement in scientific activities (desirable) Practicing in the region Main topics: Breast cancer Gynaecological cancer Lung cancer Urological cancer Gastrointestinal cancer Lymphomas Daniela Mengato, dmengato@eso.net, ph DEADLINE BY APPLICATION ONLY: 8 JULY 2018 ESO EDUCATION

32 VISITING PROFESSORSHIP MEETINGS Within the Eastern Europe and Balkan Region Programme, ESO is pleased to provide support for clinical institutes in the region to propose a Visiting Professorship Meeting (VPM) and four VPM will be supported by ESO per year. The selection will be made among suitable proposals on a first-come/first-served basis and further proposals will be assessed for the following year. The Visiting Professor is a renowned expert in the clinical oncology topic and can adequately focus on the tumour type and discipline. The hosting clinical institute is a renowned centre of reference for clinical oncology in the region whose medical team is interested in attending and actively participating in an internal educational meeting held in English. Whereas proposals by the Host Chair will be considered, the VPM is intended to span 1.5 days and the programme is discussed with the Visiting Professor. Clinical cases presented by the participants are mandatory parts of the programme. Typically, a VPM is organised in a tumour type (for instance prostate cancer) by a defined discipline (for instance, radiation oncology) and should be organized for participants. The medical/clinical oncology team of the host institute is invited by the Host Chair and attendance is free of charge. The Host Chair can also promote and invite the team of other institutes in the region/country. Application: To apply as Host Chair of a VPM please visit: Laura Richetti, lrichetti@eso.net, ph Next planned events: Breast Cancer 5-6 April 2018, Pristina, Kosovo Venue: SHSKUK-University Hospital, Klinika e Onkologjise-Oncology Clinic Host Chair: E. Hyseni, XK Visiting Professor: A. Eniu, RO Lung Cancer June 2018, Pristina, Kosovo Venue: SHSKUK-University Hospital, Klinika e Onkologjise-Oncology Clinic Host Chair: E. Hyseni, XK Visiting Professor: E. Felip, ES 30 ESO EDUCATION 2018

33 ESO OBSERVATORIES AND SESSIONS ESO Observatories are high level sessions organised during major international conferences with the aim of providing the audience with updated an unbiased information on a given topic. An ESO Observatory concentrates on a forecast of what members of the panel expect to happen in their own field of competence and expertise in the coming period. The conclusions are published at The following Observatories will be organised: 5th Prostate Cancer Observatory during the 33rd Annual EAU Congress, 16 March 2018, Copenhagen, Denmark 5th Lung Cancer Observatory during the European Lung Cancer Conference, 13 April 2018, Geneva, Switzerland 15th Colorectal Cancer Observatory during the 20th World Congress on Gastrointestinal Cancer, 20 June 2018, Barcelona, Spain Furthermore, ESO is proud to co-operate with major organisations in Europe and beyond by holding sessions in the programme of their congresses: ESO Session News on lymphomas and breast cancer in young women: report from ICML and BCY held during the 4th St. Petersburg International Oncology Forum White Nights 2018, 7 July 2018, Saint Petersburg, Russian Federation EONS-ESO session at EONS11, October 2018, Munich, Germany ESO EDUCATION

34 ESMO PRECEPTORSHIP ON IMMUNO-ONCOLOGY Comprising plenary lectures by a multidisciplinary faculty of international experts and case-based sessions, ESMO Preceptorship courses offer an enriched learning experience, thanks to their small size and emphasis on interaction with fellow participants and faculty. The courses are designed primarily for medical and clinical oncologists and aim to educate participants about the current standards of care. They are particularly suitable for young oncologists and for general oncologists wishing to update their Next planned event: 4-5 May 2018, Lugano, Switzerland Chairs: R.A. Stahel, CH - J. Haanen, NL - S. Peters, CH Application deadline: 9 March 2018 knowledge. Each course is accredited with ESMO-MORA CME (8-10 points). ESO is pleased to announce that a limited number of travel grants are made available on a competitive basis to non-esmo members interested in attending the ESMO Preceptorship on Immuno-Oncology courses in ESMO members interested in travel support opportunities are invited to visit the ESMO website. Learning objectives: Understand the basics of tumour immunology Learn about the essentials of immunotherapies and their applications in cancer medicine Learn about the status of development and clinical experience of immunotherapy in different tumour types Further courses scheduled in 2018 will be announced at and Participant s profile: Medical and Clinical oncologists Travel grants are made available to non-esmo members. ESMO member are invited to visit the ESMO website for further information on travel support Luis Carvalho, lcarvalho@eso.net, ph DEADLINE BY APPLICATION ONLY: 9 MARCH ESO EDUCATION 2018

35 CAREER DEVELOPMENT CLINICAL TRAINING CENTRES FELLOWSHIP PROGRAMME ESO s Clinical Training Centres Programme aims at giving trainee oncologists of the future the opportunity to spend a period of time in a clinical setting specially designed to address their needs. Trainees can attend a selected host centre for a period of 3-6 months with either observership status (direct contact with patients is not foreseen) or residency status (direct contact with patients is foreseen). During this period it is anticipated that participants will gain further knowledge in their specialty as well as a good overview of all the issues involved in the running of a successful cancer unit. The following centres have been selected as Clinical Training Centres: St. Vincent s University Hospital, Dublin, Ireland, under the umbrella of the University College Dublin Institut Gustave Roussy, Villejuif, France, under the umbrella of University Paris-Sud Oncology Institute of Southern Switzerland, Bellinzona, Switzerland European Institute of Oncology, Milan, Italy Istituto Nazionale dei Tumori, Milan, Italy The Royal Marsden, NHS Foundation Trust, London, United Kingdom The Christie, NHS Foundation Trust, Manchester, United Kingdom Comprehensive Cancer Centre Ulm, Ulm, Germany Champalimaud Clinical Centre, Lisbon, Portugal Erasmus MC Cancer Institute, Rotterdam, The Netherlands Training programmes: Details of the training programmes offered by each centre can be found at under the career development section. Nurses Fellowship Programme: ESO and the European Oncology Nursing Society (EONS) are offering a new fellowship programme for cancer nurses in Europe. Further information can be found at Corinne Hall, chall@eso.net, ph Grant: Successful applicants will receive the following: Travel costs to and from country of residence A monthly grant of EUR for visiting observership status and EUR for visiting residency status. Application: Details on the application and selection procedure can be found online. The 2018 Clinical Training Centres programme is supported by a Fund provided by the European School of Oncology and an educational grant from Bristol-Myers Squibb and Genomic Health. APPLICATION DEADLINES FIRST SEMESTER 2019: 30 JUNE 2018 SECOND SEMESTER 2019: 5 NOVEMBER 2018 ESO EDUCATION

36 CAREER DEVELOPMENT CERTIFICATE OF COMPETENCE IN LYMPHOMA FOURTH COHORT ( ) Chairs: J.O. Armitage, US - M. Hoechstetter, DE - F. Cavalli, CH - S. Stilgenbauer, DE The European School of Oncology in co-operation with Ulm University offers a structured Certificate of Competence in Lymphoma Programme, an academically recognised curriculum of studies, which was developed with the contribution of internationally recognised physicians and scientists in the field of haemato-oncology. Programme: The Programme, which is offered on a part-time basis using blended-learning modules and seminars, is divided in three attendance seminars (in Germany and Switzerland) and four e-learning modules. Over the duration of 14 months the Programme provides a total of 405 hours of comprehensive learning, accordingly reported with a workload of 14 European Credit Transfer and Accumulation System Points (ECTS) by Ulm University. Eligibility: The Programme is designed for oncologists and haematologists (medical oncology, haematology, internal medicine, radiation oncology, pathology), but it is equally accessible to graduates in natural sciences who are engaged in the field of oncology, especially in the field of lymphoma. Admission and deadlines: Admission to the Certificate of Competence in Lymphoma Programme is by competitive application only and the selection is based on the eligibility criteria and the selection procedure. Attendance is limited to 20 participants per cohort. Applications for the fourth edition will open in mid-may 2018 and submission is required by the deadline of 14 September Certificate: Upon successful completion of the Programme, participants will obtain an academic certificate issued by the European School of Oncology and Ulm University assigning 14 ECTS and a diploma supplement by Ulm University. Dolores Knupfer, dknupfer@eso.net, ph DEADLINE BY APPLICATION ONLY: 14 SEPTEMBER ESO EDUCATION 2018

37 CAREER DEVELOPMENT CERTIFICATE OF COMPETENCE IN BREAST CANCER THIRD COHORT ( ) Chairs: F. Cardoso, PT - J. Huober, DE - W. Janni, DE - O. Pagani, CH - F. Peccatori, IT - E. Winer, US The European School of Oncology in co-operation with Ulm University offers a structured Certificate of Competence in Breast Cancer Programme, an academically recognised curriculum of studies, which was developed with the contribution of internationally recognised physicians and scientists in the field of breast cancer. Programme: The Programme, which is offered on a part-time basis using blended-learning modules and seminars, is divided in three attendance seminars (in Austria, Portugal and Germany) and five e-learning modules. Over the duration of 13 months the Programme provides a total of 381 hours of comprehensive learning, accordingly reported with a workload of 13 European Credit Transfer and Accumulation System Points (ECTS) by Ulm University. Eligibility: The Programme is designed for physicians with experience in the field of breast cancer (medical oncology, radiation oncology, gynaecology, senology, pathology), but it is equally accessible to graduates in natural sciences who are engaged in the field of breast cancer. Admission and deadlines: Admission to the Certificate of Competence in Breast Cancer Programme is by competitive application only and the selection is based on eligibility criteria and the selection procedure. Attendance is limited to 20 participants per cohort. Applications for the third edition will open in mid-may 2018 and submission is required by the deadline of 14 September Certificate: Upon successful completion of the Programme, participants will obtain an academic certificate issued by the European School of Oncology and Ulm University assigning 13 ECTS and a diploma supplement by Ulm University. Alexandra Zampetti, azampetti@eso.net, ph DEADLINE BY APPLICATION ONLY: 14 SEPTEMBER 2018 ESO EDUCATION

38 CAREER DEVELOPMENT CERTIFICATE OF ADVANCED STUDIES IN LUNG CANCER ( ) Chairs: E. Felip, ES - M. Guckenberger, CH - R.A. Stahel, CH The University of Zurich and the European School of Oncology are proud to announce the launch of a structured Certificate of Advanced Studies in Lung Cancer, an academically recognised curriculum of studies developed with the contribution of internationally recognised physicians and scientists in the field of lung cancer and other thoracic malignancies. Programme: The Programme, which is offered on a part-time basis using blended-learning modules and seminars, is divided in three attendance seminars (two in Switzerland and one in Germany) and four e-learning modules. Over the duration of 12 months, the Programme provides a total of 420 hours work load of comprehensive learning, accordingly reported with 14 ECTS credits (European Credit Transfer and Accumulation System Points). The current edition will run from April 2018 to April Eligibility: The programme is designed for medical doctors (medical oncology, radiation oncology, thoracic surgery, radiology, nuclear medicine, pathology), but it is equally accessible to graduates in natural sciences, who are engaged in the field of oncology, especially in the field of thoracic malignancies. Admission and deadlines: Admission to the Certificate of Advanced Studies in Lung Cancer is by competitive application only and the selection will be based on the eligibility criteria and on the selection procedure. Attendance is limited to 25 participants per cohort. The application deadline for the current edition has already passed but applications for the next cohort will open in the autumn of Certificate: Upon successful completion of the Programme, participants will obtain an academic Certificate issued by the University of Zurich assigning 14 ECTS credits, equalling a work load of 420 hours and a diploma supplement by the University of Zurich. THE APPLICATION DEADLINE HAS PASSED. APPLICATIONS FOR THE NEXT COHORT WILL OPEN IN THE AUTUMN OF Alexandra Zampetti, azampetti@eso.net, ph ESO EDUCATION 2018

39 Master Online Advanced Oncology Unique curriculum preparing for leadership tasks in oncology. Study part-tim me team up intern ationall ly! Summer School Challenges & Introduction Target group: Clinical oncologists, graduates in human medicine who regularly treat cancer patients, scientists and engineers with experience in the field of oncology and the aim of becoming leaders in their field. Semester 1 Interdisciplinary Oncology - Cellular and molecular biology of cancer - Diagnostics - Principles of therapy and treatment - Epidemiology Timely and locally flexible learning: The blended learning concept comprises online-learning and face-toand f ace seminars. It allo ws you to combine work, family study. High scientific and clinical quality: The program is founded by international renowned experts and orga- nizations. Top-class cooperating partners, such as the Comprehensive Cancer Center Ulm and the European School of Oncology enrich the competencies. Split-role tutoring support: Specifically developed for participants strongly engaged in their professional life. Individual contact persons are available to answer technical, organizational and professional questions. The study program starts in October. It is completed with the academic degree» Master of Science«. There are four attendance seminarss at Ulm University and one in colla- boration with the European School of Oncology (ESO). Semester 4 Semester 3 Semes ster 2 Clinical Research - Biometry - Clinical trials - Ethical aspects - Project Management Advanced/Integrated Therapies - Clinical oncology I - Clinical oncology II - Integrated therapeutic concepts Management - Business basics - Health care systems - Management of processes, entities and people - Quality control Master`s Thesis Summer School Future Perspectives Ap plication D eadline: April 15 Uta Schmidt-Strassbur ger PhD Phone: masteroncology@uni-ulm. de th ww ww.masteroncology. de

40

41

42 INTERNATIONAL ONLINE MASTER DEGREE IN GYNAECOLOGICC ONCOLOGY Direction Ignacio Zapardiel MD PhD. Gynecologic Oncology Unit, La Paz University Hospital. Associate Professor UAM University. Scientific Assistant Director IdiPAZ - Biomedical Research Institute. Authors of refe erence The contents of the course are developed by specialists and university pro- fessors with wide experience and renowned prestige, who will present major news on the area taking into account the latest scientific research: Dr. Giovanni Aletti / Dr. Frederic Amant / Dr. Rebeca Díaz / Dr a. María Dolores Diestro Tejeda / Dr. Antonio Gil-Moreno / Dr. Walter Gotlieb Dr a. Cristina González Benítez / Dr. Sara Iacoponi / Dr. Vesna Kesic / Dr. Paul M. Magtibay / Dr. Alejandra Martínez / Dr. Sergio Martínez Román / Dr. Noriomi Matsumura / Dr. Elisa Moreno Palacios / Dr. Shannon Salvador / Dr. José Luís Sánchez-Iglesias / Dr. Javier de Santiago García / Dr. Javier de la Torre Fernández de Vega / Dr. Vanna Zanagnolo Giant ovarian tumor Learning tools The online Master Degree in Gynaecologic Oncology performs a formative action which favours the connection, learning, involvement and knowledge building through the best high-quality multimedia contents. Each Module within the course includes training activities with a practical, active and participatory aim implemented via several resources: Study material Video surgical techniques and clinical procedures Interactive summariess Case studies with expert assessment Test sting & Retesting Master lessons Contents Module 1 Module 2 Module 3 Module 4 Module 5 Module 6 Module 7 Cancer Basics Endometrial Endometrial Cervical Cancer I Cerv Cancer I Cancer II vical Cancer II Ovarian Cancer I Ovarian Cancer II Module 8 Vulvar Cancer I Module 9 Vulvar Cancer II Module 10 Uterine Sarcom a I Module 11 Uterine Sarcom a II Module 12 Cancer and human reproduction Module 13 Module 14 Rare gynecological tumors Palliative Care Concepts Complementary reading Fast-track guidelines info@cursosmedicina.com (+ +34)

43 MEDIA ACTIVITIES The aim of ESO s media activities is to promote and reward intelligent and critical coverage of cancer and cultivate a more positive but realistic image of the disease that is developed through several activities that are described herefter. Cancer World Journalism Award The international magazine Cancer World is looking for outstanding pieces of journalism published between October 2016 and April 2018 that are changing the way we think about cancer. The Cancer World Journalism Award encourages, celebrates and rewards journalists who deliver insights into the personal and social impact of the disease, and efforts to change policy, practice or advocacy. We are looking for journalists to submit one or more items of their work whether in print, online, on radio, video or television - into the following categories: Patient and carer experience Research, science and treatment Policy, services and affordability Prevention In all categories, we are looking for articles/programmes that move beyond documenting experience, science, policy and practice. We want to find work that challenges, addresses urgent questions, increases awareness and prompts change. We are particularly looking for serious investigative journalism. A prize of 1500 is available for the winner in each category. The journalist judged the overall winner will also be funded to attend the 2018 ECCO Summit in Vienna (7th-9th September 2018), where he/she will be presented with their award. The closing date for entries is 1st May Find out more at Cancer World Journalist Network ESO has created a Cancer World Journalist Network group on Facebook for cancer reporting journalists worldwide. Members of the group help, support and encourage each other to further develop their cancer reporting skills. They can also submit proposals for short news and opinion pieces for the Cancer World website as well as apply for a Cancer World Journalist Grant and be funded by ESO to complete a story on a cancer-related topic. Further information is available by contacting Corinne Hall - chall@eso.net ESO EDUCATION

44

45 EL SEVIER ER S ONCO OLOGY OGY JO URNAL S PUBL ISH HI GH QU ALITY RESEARC EARC CH THE BREAST Edi itor-in-chief: Fatima Cardoso The Breast is an international, multidisciplinary jo urnal for res searchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer pre evention, diagnosis and treatment of all stages of the disease. Top Cited Articles: CRITICAL REVIEWS IN ONCOLOGY/HEMATO OLOGY Edi itor-in- hief: i Sign u p for the OncologyAdv vance newsletter thebreastonline.com Cri itical Reviews in Oncology/Hematology publishes scholarly, crit tical reviews in all fields of oncology and hematology written by experts from around th e world. Top Cited Articles: croh-online.com For inf formation on how to submit your paper, visit th he journal webpage. Visit OncologyAdvance.com

46 TJ Tumori Journal Impact Factor: The Gianni Bonadonna Lecture Series De Vita and Canellos, US Cassinelli, Italy Imbimbo and Blackhall, Italy/UK Banerjee, UK Cremolini, Italy Kaasa, Norway Viviani and Pileri, Italy Benjamin, US Bellmut, US Valdagni, Italy Licitra, Italy Barr and Bleyer, US Heng et al, US ESO Recommended

47 Breast Centres Network Bre ast Centres Network S ynergy y among Breast Units A project of Need to quickly contac t a breast expert collegue? I s your B reast Unit org a nised according to state-of-t he-art internat ional standard s? Don t miss the opportunity to discover more and i mprove your Breast Unit! B ecome a Bre a st Centres N etwork Member astcentresnetwork.org Breast Centres Network is the first internation al network of clinical centres exclusively dedicated to the diagnosis and treatment of breast cancer. It is a project of ESO (European School of Oncology) with the aim to promote and improve breast cancer care in Europe and throughout the world. Our network includes Breast Units (Multidiscip plinary Breast Centres) that fulfill minimum requirements (see Eligibility Gate) to be considered referral centres. Organisation of Multidisciplinary Breast Units is recommended by EUSOMA, Europa Donna (European Breast Cancer Coalition) and the European Parliament. In the US, breast center accreditation is offered by the National Accreditation Program for Breast Centers. We offer an online Breast Unit Directory that provides detailed information at a glance about our members in an attempt to broadcast the state-of- the-art international standards for multidisciplinary breast cancer care. Morethan centress onl li ine!! Membership is free! And it ll really make a difference to your center! G O SOCIAL! #BCN_ES O

48 Prostate Cancer Units Network Synergy among Prostate Cancer Units Is your Prostate Cancer Unit organised with a multidisciplinary and multiprofessional team of experts and according to state-of-the-art international standards? Don t miss the opportunity to discover more and improve your Prostate Cancer Unit! Photo: Sunflower - Photographer: 2009 Mikael Hvidtfeldt Christensen Become a Prostate Cancer Units Network Member Membership is free! Prostate Cancer Units Network is the first international network of clinical units dedicated to the diagnosis and treatment of prostate cancer. The project is an initiative of the European School of Oncology in partnership with Europa Uomo - the European Prostate Cancer Coalition - with the aim to promote the multidisciplinary and multiprofessional management of prostate cancer patients. Our network includes Prostate Cancer Units that fulfil minimum requirements (see Eligibility Gate) to be considered referral centres. This website offers an online Prostate Cancer Units Directory that provides detailed information about our members in the attempt to broadcast the state-of-the-art standards for multidisciplinary prostate cancer care. And it ll really make a difference to your unit! Prostate Cancer Units Network is a project of: In partnership with and with the endorsement of

49 Improved Imaging with High Quality Education Ultrasound X-ray Mammography MR Imaging Detection Diagnosis Management Interventional Techniques Pathological Correlations IBUS is the leading international provider of a range of courses covering all aspects of breast imaging Since 1991, IBUS courses have been held in Europe, North and South America, Asia, and Africa The IBUS Breast Imaging School has an international faculty of more than 40 experts To date, nearly 120 courses have been succesfully completed with more than 12,000 participants Courses consist of didactic presentations, panel discussions, interactive case presentations, and hands-on practical workshops that form an essential part of the course content Course information: info@ibus.org ESO recommended

50 Improving and extending the lives of women and men living with advanced breast cancer (ABC) in all countries worldwide The ABC Global Alliance is a multi-stakeholder platform for all those interested in collaborating in common projects relating to advanced breast cancer (ABC). We invite individuals and organisations interested in advanced breast cancer to join our efforts! The ABC Global Alliance is an ESO initiative also sponsored through unrestricted grants provided by: Main sponsors: ABCglobalalliance@eso.net FIND US

51 TEAM AND WHO S WHO AT ESO (2018) FOUNDERS BOARD OF DIRECTORS President Members L. Del Drago, Rome U. Veronesi, Milan U. Rock, Milan M. Alloisio, Milan A. Azario, Milan P. Biandrino, Milan A. Costa, Milan (CEO) V. Finizzola, Milan T. Galdy, Florence F. Gubitosi, Milan P. Maestro, Milan L. Pellegrini, Rome R. Tarricone, Milan G. Ventura, Milan L. Vita Samory, Milan PROGRAMME COORDINATORS Breast Cancer Eastern Europe and Balkan Region (EEBR) Eurasia Gynaeco-oncology Latin America and Mediterranean Region Lung Cancer Lymphoma Prostate Cancer Rare Tumours F. Cardoso, Lisbon A. Eniu, Cluj-Napoca F.A. Peccatori, Milan (Chair) M. Aapro, Geneva A. Barchuck, Saint Petersburg T. Semiglazova, Saint Petersburg S. Tjulandin, Moscow C. Sessa, Bellinzona M. Aapro, Geneva E. Felip, Barcelona E. Zucca, Bellinzona R. Valdagni, Milan P. Casali, Milan Auditors SCIENTIFIC COMMITTEE Chairman CEO Scientific Director Members DEPARTMENT COORDINATORS Cancer World e-eso Masterclass Clinical/ Medical Oncology Sharing Progress in Cancer Care (SPCC) World Oncology Forum M.B. Lovati, Milan (Chairman) B. Negri, Milan S. Sarubbi, Milan F. Cavalli, Bellinzona A. Costa, Milan and Lugano F.A. Peccatori, Milan A. Albini, Milan F. Calvo, Pamplona A.M.M. Eggermont, Paris S. Kaye, Sutton P. Naredi, Göteborg L. Norton, New York C. Rolfo, Antwerp L. Sharp, Stockholm (EONS) S. Stilgenbauer, Ulm E.P. Winer, Boston P. Workman, Sutton A. Costa, Milan and Lugano M. Siano, St. Gallen N. Pavlidis, Ioannina M. Aapro, Geneva F. Cavalli, Bellinzona TEAM Chief Operating Officer Administration Office Latin-American Programme and Event Organisation Editorial Office Event Organisation Rare Tumours Programme Editorial and Media Office, Clinical Training Centres Fellowship Programme EEBR, Lymphoma Programme and Event Organisation Communication Breast Cancer Programme, e-eso and Event Organisation SPCC, Eurasia and Mediterranean Programmes and Event Organisation Bibliography Prostate Cancer Programme, ABC Global Alliance and Event Organisation WOF, CCB, CASLu and Event Organisation C. Melcher L. Camarini, P. Gatti L. Carvalho J. Costa Buranelli A. Ciocchini, E. Fiore, L. Richetti M. Fregonese C. Hall D. Knupfer G. Maggini F. Marangoni D. Mengato W.S. Russell-Edu R. Ventura A. Zampetti ESO is supported by Fondazione per la Formazione Oncologica, President: A. Perricone, Milan ESO Foundation, President: C. Maggini, Bellinzona ESO EDUCATION

52 Milan Via Turati, Milano - Italy Phone: Fax: eso@eso.net Bellinzona Piazza Indipendenza, Bellinzona - Switzerland Phone: Fax: